BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27373362)

  • 1. [Analysis of treatment and prognosis in post-operative patients with urachal carcinoma].
    Niu HT; Dong P; Wang JN; Huang J; Zeng YX
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1923-5. PubMed ID: 27373362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urachal carcinoma: clinicopathological features, treatment and outcome.
    Kumar N; Khosla D; Kumar R; Mandal AK; Saikia UN; Kapoor R; Singh SK; Sharma SC
    J Cancer Res Ther; 2014; 10(3):571-4. PubMed ID: 25313741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
    Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
    Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 14 cases of urachal carcinoma].
    Chen ZF; Wang F; Qin ZK; Dai YP; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Ye YL
    Ai Zheng; 2008 Sep; 27(9):966-9. PubMed ID: 18799037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
    Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urachal carcinoma: a pathologic and clinical study of 46 cases.
    Dhillon J; Liang Y; Kamat AM; Siefker-Radtke A; Dinney CP; Czerniak B; Guo CC
    Hum Pathol; 2015 Dec; 46(12):1808-14. PubMed ID: 26364859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical and chemotherapeutic options for urachal carcinoma: report of ten cases and literature review.
    Yazawa S; Kikuchi E; Takeda T; Matsumoto K; Miyajima A; Nakagawa K; Oya M
    Urol Int; 2012; 88(2):209-14. PubMed ID: 22143067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urachal carcinoma: experience of a clinical center within 30 years].
    Shao GJ; Cai L; Li XS; Song G; Li XY; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):774-8. PubMed ID: 24136277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Extraperitoneal and Transperitoneal Laparoscopic Extended Partial Cystectomy for the Treatment of Urachal Carcinoma.
    Wang B; Li X; Ming S; Ma X; Li H; Ai Q; Zhang X
    J Endourol; 2016 Mar; 30(3):280-5. PubMed ID: 26531333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urachal carcinoma: Impact of recurrence pattern and lymphadenectomy on long-term outcomes.
    Duan F; Zhai W; Zhang B; Guo S
    Cancer Med; 2020 Jun; 9(12):4166-4174. PubMed ID: 32329250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients.
    Zaghloul MS; Nouh A; Nazmy M; Ramzy S; Zaghloul AS; Sedira MA; Khalil E
    Urol Oncol; 2006; 24(1):13-20. PubMed ID: 16414487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoma of urachus: report of 15 cases and review of literature--is total cystectomy the treatment of choice for urachal carcinoma?].
    Asano K; Miki J; Yamada H; Maeda S; Abe K; Furuta A; Suzuki M; Onishi T; Kido A; Ueda M; Kawakami M; Onodera S; Oishi Y
    Nihon Hinyokika Gakkai Zasshi; 2003 May; 94(4):487-94. PubMed ID: 12795163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience.
    Siefker-Radtke AO; Gee J; Shen Y; Wen S; Daliani D; Millikan RE; Pisters LL
    J Urol; 2003 Apr; 169(4):1295-8. PubMed ID: 12629346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the bladder: study of 14 cases and review of the literature.
    Kamat MR; Kulkarni JN; Tongaonkar HB
    Br J Urol; 1991 Sep; 68(3):254-7. PubMed ID: 1913065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic partial cystectomy with en bloc resection of the urachus for urachal adenocarcinoma.
    Hong SH; Kim JC; Hwang TK
    Int J Urol; 2007 Oct; 14(10):963-5. PubMed ID: 17880303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical experience with urachal carcinoma].
    Martínez-Cornelio A; Flores-López D; Ojeda RF; Quintero-Becerra J; Hernández-Toriz N
    Cir Cir; 2009; 77(1):33-8. PubMed ID: 19344561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
    Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
    Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma of bladder.
    Dandekar NP; Dalal AV; Tongaonkar HB; Kamat MR
    Eur J Surg Oncol; 1997 Apr; 23(2):157-60. PubMed ID: 9158192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.